Stocks
Denali Therapeutics (DNLI) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -213.2 | 62.7 | -295.8 | -330.4 | -180.0 | -201.6 | ||
| Changes by years, y/y, % | +360% | -129% | -572% | +12% | -46% | +31.2% | |||
Denali Therapeutics. EBITDA US GAAP, bln rub
Denali Therapeutics. EBITDA US GAAP, changes, %
Denali Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Denali Therapeutics (DNLI) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -120.8 | 170.5 | -111.6 | -130.4 | -130.1 | -201.6 | |
| Changes by years, y/y, % | +88% | -387% | +6% | +29% | +8% | |||
| Changes by quarters, q/q, % | +19% | -241% | -165% | +17% | 0% | |||
